HHS vs MSFT: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

MSFT has stronger fundamentals based on our AI analysis.

HHS
HARTE HANKS INC
SELL
76%
Confidence
VS
MSFT
MICROSOFT CORP
BUY
91%
Confidence

HHS vs MSFT Fundamental Comparison

Metric HHS MSFT
Revenue $159.6M $158.9B
Net Income $-811,000.0 $66.2B
Net Margin -0.5% 41.7%
ROE -4.0% 16.9%
ROA -0.9% 10.0%
Current Ratio 1.54x 1.39x
Debt/Equity 0.00x 0.10x
EPS $-0.11 $8.87

Green = Better metric | Red = Weaker metric

View Full HHS Analysis →
View Full MSFT Analysis →

You Might Also Compare

HHS vs AAPL MSFT vs GOOGL HHS vs AMZN MSFT vs NVDA

HHS vs MSFT: Frequently Asked Questions

Is HHS or MSFT a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), MSFT has stronger fundamentals. HHS is rated SELL (76% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.

How does HHS compare to MSFT fundamentally?

HARTE HANKS INC has ROE of -4.0% vs MICROSOFT CORP's 16.9%. Net margins are -0.5% vs 41.7% respectively.

Which stock pays higher dividends, HHS or MSFT?

HHS has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in HHS or MSFT for long term?

For long-term investing, consider that HHS has SELL rating with 76% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about HHS vs MSFT?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HHS vs MSFT, the AI consensus favors MSFT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.